Comparative effectiveness research (CER) has been in the spotlight since Congress passed the American Recovery and Reinvestment Act of 2009. This session will provide a background on CER, including the allocation of $1.1 billion of federal funding for its advancement. Speakers will explore the research and policy through a variety of lenses and access points. The thread through the discussion will be how to create a system with informed decision-making at its core.
Robert T. Croyle — Director, Division of Cancer Control and Population Sciences, National Cancer Institute, National Institutes of Health
Glenna Crooks — President, Strategic Health Policy International, Inc.
Stephanie Mensh — Vice President Reimbursement Policy, NeoCure Group